Patented Platform Technology
Our patented biotechnology platform forms the scientific foundation of all Murnia® healthcare technologies developed to protect, regenerate, and restore skin and mucosal tissues.
Granted on three continentsRefreshes, Protectsand Moisturizesthe Skin
Patented healthcare technologies for the protection, regeneration, and restoration of skin and mucosal tissues.
WO2020072987US 11,331,360 B2EP3860633 B1
The Murnia® platform
One patented molecular compound; the shared foundation of eight healthcare technologies.
Clinically Validated
Our healthcare technologies are supported by laboratory research, analytical testing, and clinical evidence, ensuring safety, reliability, and clinical performance.
Double-blind clinical studyGlobally Scalable
Our technologies are developed in alignment with international regulatory standards and designed for global market adoption and scalable healthcare solutions.
ISO 13485 quality system14 August 2026 · Teknopark İstanbul
Awarded for Success in International Support Programmes at the Vecihi Hürkuş Technology Awards
At Teknopark İstanbul's 9th Vecihi Hürkuş Technology Awards, Umayana® was recognised for its success in international support programmes. Our research and development continues at Teknopark İstanbul.
About Us
Science that reaches the patient
Umayana® Biotechnology is a science-driven regenerative biotechnology company developing patented healthcare technologies for the protection, regeneration, and restoration of skin and mucosal tissues.
Our proprietary Murnia® platform combines biotechnology, advanced biomaterials, and clinical research to develop innovative medical technologies for oncology supportive care, advanced wound management, dermatology, and veterinary medicine.
Working closely with physicians, hospitals, and research institutions, we transform scientific discoveries into clinically validated healthcare solutions that improve patients’ quality of life while supporting more sustainable healthcare systems.
Murnia®
Patented platform technology
At a glance
0
Granted patent families (WO / US / EP)
0
Murnia® healthcare technologies
0
International congress presentations
0
Petroleum-derived ingredients
Our Science
A bioactive layer that protects while tissue repairs itself
Murnia® forms a bioactive protective layer while supporting the regenerative processes of the underlying tissue. Its optimized bioadhesive technology enables prolonged contact with skin and mucosal surfaces, creating an ideal environment for tissue repair.
- Antioxidant activity
- Protection against oxidative stress
- Tissue regenerative activity
- Collagen and elastin synthesis support
Products
The Murnia® range
Barrier gels, sprays, creams, emulsions and tonics — every one of them built on the same patented molecular compound.
Medical Device Class IGelMurnia® Barrier Gel
A patented barrier gel that forms a protective layer on the oral mucosa.
LipsMouth
Read more
Medical Device Class IGelMurnia® Barrier Gel-A
Reinforces the skin's mechanical resistance in high-risk, macerated areas.
Skin
Read more
Umayana®SprayMurnia® Mouth Spray
Alcohol-free oral spray formulated at the pH of natural saliva.
LipsMouth
Read more
Umayana®EmulsionMurnia® Cleansing Emulsion
Cleanses without disturbing the skin barrier, thanks to patented myrrh extract.
CleanMoisteningSkin
Read moreInternational recognition
Backed by the institutions that set the standard
Umayana® holds the European Commission’s Seal of Excellence for 2025-2026 and is co-funded by the European Union. Our sustainable innovation approach has also been recognised within the United Nations Global Cleantech Innovation Programme (UN GCIP).
Vecihi Hürkuş Technology Awards 2026
Success in International Support Programmes — presented at Teknopark İstanbul's 9th Vecihi Hürkuş Technology Awards, 14 August 2026.
Seal of Excellence 2025-2026
Awarded by the European Commission to project proposals evaluated as high-quality within the EU’s competitive funding programmes.
Co-funded by the European Union
Umayana® Biotechnology’s regenerative healthcare research is co-funded by the European Union.
Teknopark İstanbul
Umayana® develops and tests its patented platform at Teknopark İstanbul, Türkiye's leading technology park.
UN GCIP
Recognised within the United Nations Global Cleantech Innovation Programme for sustainable innovation.
UNIDO
Supported through the United Nations Industrial Development Organization ecosystem.
Let’s talk about distribution, clinical use or investment
Explore our products distribution opportunities or connect with us as an investor.